Biopreservation Global Market Report 2023

The biopreservation is defined as use of microorganisms and their metabolic by products to increase food safety and shelf life. It is used to preserve biospecimens for a longer period and shield them from any harm outside their native environment. Biospecimens are samples of materials such as urine, blood, tissue, cells, DNA and others, kept in a bio repository for future research or utilized for a lab test.

The main types of biopreservation are biopreservation equipment and biopreservation media. Biopreservation equipments are instruments such as bio-based therapeutics, clinical biomarkers, cells, viruses, diagnostic biochips, and others that preserve biospecimens. It is used for many biospecimens including human tissue samples, organs, stem cells, and others. It is applied for therapeutic applications, research applications, clinical trials, and other and are used by biobanks, gene banks, hospitals, and others.

The global biopreservation market is expected to grow from $4.92 billion in 2022 to $5.51 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biopreservation market is expected to reach $8.50 billion in 2027 at a CAGR of 11.5%.

The biopreservation market research report is one of a series of new reports that provides biopreservation market statistics, including biopreservation industry global market size, regional shares, competitors with a biopreservation market share, detailed biopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the biopreservation industry. This biopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Technological innovation is a key trend in the biopreservation market. Major players are adopting the new technologies such as next-gen cryopreservation solutions, integration and design with nanoscale technology, and standardization of hypothermic storage for preserving complex tissues and organs are over time. Cryopreservation is the process of safeguarding material at an extremely low temperature (196 °C) either very quickly, as in the case of seed storage, or gradually, with simultaneous dehydration, as in tissue culture. For instance, in September 2021, AMSBIO, a US-based quality life science research reagents and services provider, launched a next-generation cryopreservation product STEM-CELLBANKER EX. STEM-CELLBANKER EX is a cryopreservation media solution which eliminates the requirement for the customary washing procedures necessary for the creation of cell therapy products. It has demonstrated remarkable post-thaw cell viability and recovery.

In January 2020, Royal DSM, a Netherlands-based corporation focused on health, nutrition and materials acquired Koninklijke CSK Food Enrichment C.V (CSK) for $166 million (€150 million) . With this acquisition, DSM intends to expand upon its array of food and beverage products, as well as its knowledge of expanding global markets and trends. CSK is a Netherlands-based company specializing in bio-based dairy.

North America was the largest region in the biopreservation market in 2022. The regions covered in the biopreservation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Increasing demand for personalized medicine is significantly contributing to the growth of the biopreservation market. Personalized medicine is used to treat patients with diseases specific to them. Personalized medicines are developed with the help of biobanks which preserve human tissues and cells by using biopreservation. For instance, in September 2021, the Swedish Government invested SEK 220 million ($1.87 million) in the Swedish national infrastructure Genomic Medicine Sweden (GMS) to make it easier to keep integrating precision medicine into Swedish healthcare. It ensures that every person can access more accurate tests and individualized care. Such investments are taking place due to a rise in demand for personalized medicines. Thus, the increasing demand for personalized medicine is expected to propel the biopreservation market growth going forward.

The biopreservation market includes revenues earned by entities by providing freezing services, cryogenic, storage systems services, thawing equipment, and sample refrigeration services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified) .

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Major players in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC., Custom Biogenic System, BioCision LLC, Princeton Cryotech Inc., Lifeline Scientific Inc., Biomatrica Inc., Exact Sciences Corporation, QIAGEN, ThermoGenesis Holdings Inc., Stirling Ultracold , MVE Biological Solutions, Taylor-Wharton, and X-Therma Inc.



This product will be delivered within 1-3 business days.